Identification of Adverse Drug Reaction By Apriori Association Rule Learning

Size: px
Start display at page:

Download "Identification of Adverse Drug Reaction By Apriori Association Rule Learning"

Transcription

1 Global Journal of Pure and Applied Mathematics. ISSN Volume 13, Number 11 (2017), pp Research India Publications Identification of Adverse Drug Reaction By Apriori Association Rule Learning 1 Deepa Lakshmi. K. M and 2 Vijaya M. S. 1 Research Scholar, 2 Associate Professor, 1, 2 Department of Computer Science, 1, 2 PSGR Krishnammal College for women, Coimbatore, India. Abstract An unfavorable drug response (ADR) is an undesirable or unsafe response experienced after the organization of a drug or blend of drugs under typical states of utilization, which is suspected to be identified with the drug. The response might be a known side effect of the drug or it might be new and already unrecognized. Quick discovery and recording of unfriendly drug responses is essential with the goal that dangers are recognized immediately and fitting administrative move is made to guarantee that solutions are utilized securely. Suspected ADRs to any helpful operator ought to be accounted for, including drugs, blood items, antibodies, radiographic difference media, integral and natural items. In this work, we provide details regarding a novel Association learning way to deal with foresee the side effects of a given drug, mulling over data on different drugs and their side effects. Beginning from a question drug, a blend of accepted relationship investigation and networkbased diffusion is connected to foresee its drug targets. We assess our technique by measuring its execution in a cross approval setting utilizing a far reaching informational collection of 692 drugs and their known side effects got from bundle embeds. For 34% of the drugs, the best scoring side effect coordinates a known side effect of the drug. Surprisingly, even on concealed information, our strategy can surmise side effects that very match existing learning. Keywords: [Drug side effect, drug target, network diffusion, prediction.]

2 7736 Deepa Lakshmi. K. M and Vijaya M. S. 1. INTRODUCTION An unfavorable drug response (ADR) is an undesirable, undesirable effect of a solution that happens amid normal clinical utilize. Unfriendly drug responses happen every day in social insurance organizations and can antagonistically influence a patient's personal satisfaction, frequently causing considerable bleakness and mortality. Much consideration has been given to recognizing the patient populaces most in danger, the drugs most usually mindful, and the potential reasons for ADRs. An expansion in the quantity of drugs available, a maturing populace, and an upward pattern in polypharmacy are contributing elements to the commonness of ADRs around the world. Unfavorable drug responses may make patients lose trust in or have negative feelings toward their doctors and look for self-treatment alternatives, which may thus encourage extra ADRs. Around 5% of all doctor's facility confirmations are the consequence of an ADR, and around 10% 20% of inpatients will have no less than one ADR amid their healing facility stay (Kongkaew 2008; Lundkvist 2004; Pirmohamed 1998). The genuine frequency of ADRs might be significantly more prominent on the grounds that some ADRs copy characteristic sickness states and may therefore go undetected and additionally unreported. Albeit some ADRs present as minor side effects, others are not kidding and cause demise in upwards of 0.1% 0.3% of hospitalized patients (Lazarou 1998; Pirmohamed 1998). Unfavorable drug responses ought to be immediately recognized and figured out how to restrain their adverse effects on the patient. The cost of overseeing ADRs can be high, regardless of whether they happen in the inpatient or the outpatient setting. Since the clinical determination of an ADR is not generally self-evident, experts regularly arrange extra research center tests or methodology to examine the reason for a patient's ADR. 2. PRIOR WORKS ON ADR Most medicines are molecules that partner and interfere with an appropriate protein target associated with a disease of interest. Prescriptions may in like manner speak with additional proteins (off-targets starting now and into the foreseeable future) that are not their basic supportive targets, realizing startling side effects. Sedate responses are mind boggling wonders credited to various nuclear circumstances (e.g. absorption issue, downstream pathway annoys), among which the association with off-target proteins is the most fundamental reason (Blagg, 2006; Whitebread et al., 2005). Sudden drug practices got from off-targets are commonly undesired and harmful; in any case, they can on occasion be worthwhile and provoke unmistakable helpful signs. For example, sildenafil (Viagra) was made to treat angina, yet it is by and by used for the treatment of erectile brokenness.

3 Identification Of Adverse Drug Reaction By Apriori Association Rule Learning 7737 There are numerous prescriptions whose goal proteins (checking the basic target and off-targets) have not yet been portrayed. The recognizing confirmation of each and every potential concentration for a given solution has transformed into a key issue in pharmaceutical repositioning to reuse known meds for new accommodating signs. Drug target affiliations are an outstandingly expensive and dull process, and consequently there is a strong inspiration to become new insilico desire methodologies, which will engage to control testing. Starting late, the field of chemogenomics has immediately grabbed hugeness, on a very basic level exploring the association between the engineered space of possible blends and the genomic space of possible proteins (Dobson, 2004; Kanehisa et al., 2006; Stockwell, 2000). An arrangement of in silico chemogenomic procedures have been created to anticipate drug target or compound protein associations on a comprehensive scale (Bleakley and Yamanishi, 2009; Faulon et al., 2008; Jacob and Vert, 2008; Keiser et al., 2009; van Laarhoven et al., 2011; Yamanishi et al., 2008). The key idea is that practically identical ligands are most likely going to coordinate with relative proteins, and gauge is performed in perspective of manufactured structures of ligand blends, protein groupings of targets and the starting at now known compound protein associations. Another promising strategy is to use pharmacological information, for instance, cure indications and threatening solution reactions. The usage of side effect comparability has been starting late proposed to instigate whether two medicines share a target (Campillos et al., 2008). This technique requires quiet package implants that depict the ordered manifestation information, so it is applicable just to publicized meds for which response information is given. To beat this constrainment, a couple of techniques have been proposed to predict cloud responses from manufactured structures (Atias and Sharan, 2011; Yamanishi et al., 2010). These systems are useful when substance structures and responses are related with each other to some degree. In any case, there are still some drug target collaborations that can't be cleared up or expected using these strategies. 3. IDENTIFICATION OF THE DISEASE-SIDE EFFECT ASSOCIATIONS Both disease-drug associations and drug-se associations are required to infer disease-se associations. We extracted the indications of drugs from Pharm GKB to provide the disease-drug associations [19]. The SEs printed on the drug label provide consistent and reliable data as these are summarized from large clinical trials, and the drug label is approved and standardized by regulatory agencies. The SIDER database [4], which has been used to predict drug off-targets, provides a mapping extracted from drug labels of 888 approved drugs to 584 side effects. These 888 drugs map to 303 drugs and 145 diseases in Pharm GKB. We used the binary fact of the SE s presence on the drug label as listed in SIDER. Similar to generating gene- SE associations in ref [20], we inferred disease-se associations by counting the

4 7738 Deepa Lakshmi. K. M and Vijaya M. S. number of the drugs listing or not listing a SE when indicated or not indicated for a disease, generating a confusion matrix as shown in fig 1.0. The association strength of a disease-se pair is measured using multiple criteria, including the Matthew s correlation coefficient (MCC), sensitivity (sn) and specificity (sp). We computed 84,680 confusion matrices for each pair of 145 diseases and 584 SEs. 3,175 (3.75%) of these associations were considered possibly informative (using multiple criteria as described in Methods) True Positive 18 False positive MCC 0.5 _ 4 False Negative 271 True Negative Sensitivity= 10/(10+4)=0.7 Specific= 271/(271+18)=0.9 Fig 1.0 We explored a couple of the 3,175 relationship to comprehend what these affiliations inferred and how they could be utilized to recommend new signs. A portion of the affiliations have an unequivocal clarification in light of the present learning of the MOA. The SE positive antinuclear antibodies show the nearness of immune system antibodies and have all the earmarks of being related with stroke. It is the SE shared by drugs treating stroke, for the most part ticlopidine and a few angio strain changing over compound (ACE) inhibitors. Stroke is related with serious safe concealment [21]. In this manner, possibly drugs that are related with expanding invulnerable reaction as far as positive ANA may help stroke patients, however obviously an immune system reaction is not alluring. Generally speaking, half of the drugs treating stroke list this SE, while just 2% of the drugs not demonstrated for stroke list positive ANA as a SE. This 2% (regularly named false positives) incorporates a few statins and ramipril. A few statins are related with positive ANA, however are not demonstrated for stroke. In any case, a meta-investigation of 120,000 patients crosswise over 42 trials demonstrated that statin treatment gives assurance to all-cause mortality and non hemorrhagic strokes [22]. Ramipril, which additionally records positive ANA as a SE, demonstrated a 32% hazard lessening for stroke [23]. DRo SEf is recommending that the resistant related SEs of these drugs straightforwardly demonstrate their utilization for stroke, and this has likewise as of late been perceived tentatively [23].

5 Identification Of Adverse Drug Reaction By Apriori Association Rule Learning 7739 Cytomegalovirus disease is an indication of a debilitated invulnerable framework [24]. Drugs that lessen safe reaction are frequently used to counteract transplant dismissal, in this manner drugs that rundown expanded cytomegalovirus (CMV) diseases as a SE might be great possibility for treating transplant patients. Methotrexate, an antineoplastic drug records CMV contaminations as a SE. As a dihydrofolic corrosive reductase inhibitor, it is authoritatively utilized as an antineoplastic, yet has been accounted for the off-mark utilization of avoiding transplant dismissal [25]. DRoSEf recommends that drugs that rundown porphyria as a SE may go about as antidiabetics. In an investigation of 328 Swedish patients with porphyria, the 16 patients that created diabetes all had their porphyria side effects settled [26]. Valproic corrosive, pyrazinamide, naproxen, and estradiol all rundown porphyria as a SE yet are not demonstrated for diabetes. Valproic corrosive is a hostile to convulsant and a current report thought that it was effective in bringing down blood glucose levels in Wfs1 knockout mice [27]. Pyrazinamide is a hostile to tuberculosis operator, and sort II diabetes is a known hazard factor for tuberculosis [28]. In mice, naproxen is utilized as an instrument to postpone or keep the advancement of sort II diabetes from a prediabetic condition [29]. In a twofold blinded, randomized fake treatment controlled clinical trial on ladies with sort II diabetes, oral estradiol altogether diminished fasting glucose [30]. 3.1 Objectives The main objectives of this research are to distinguish adverse drug reactions (ADRs) from adverse drug events. The very next primary objective is to devise methods for ADR detection, and predict an ADR when it presents. Finally the research routes to discover various worldwide ADR reporting methods and learn how to report ADRs. 3.2 Algorithm for Association Novel Apriori Algorithm is one of the conventional algorithms to find association rules among the data inside a database or dataset. These rules are mostly found based on transactions and items inside a database. In this discussion, item refers to a set of interrelated data, which conveys a concept (object or entity), among which some associations are supposed to be found. In fact, an item can be single member and only include one piece of data. A set of items which are put beside each other and construct a work unit with a record is called transaction.

6 7740 Deepa Lakshmi. K. M and Vijaya M. S. Modified Novel Apriori Approach Input: The dataset (D) and minimum support (min_sup) Output: The maximum frequent itemset 1. Read the dataset into a 2D array and store the information of the database in binary form in the array with transactions as rows and itemset as columns. 2. k Find frequent itemset, Lk from Ck, the set of all candidate itemset. 4. Form Ck+1 from Lk. 5. Prune the frequent candidates by removing itemset from Ck whose elements do not come at least k-1 times in Lk.. 6. Modify the entry in the 2D-array in memory to be zero for the itemset which are not occurring in any of the candidates in Lk. 7. Check the Size of Transaction (ST) attribute and remove transaction from 2Darray where ST<=k. 8. k k Repeat 5-8 until Ck is empty or transaction database is empty. Step 5 is called the frequent itemset generation step. Step 6 is called as the candidate itemset generation step and step 7-9 are prune steps. 4. EXPERIMENTAL PROTOCOL There are for the most part two reasonable circumstances for drug target distinguishing proof. The primary circumstance is that the drug has no less than one known target protein and we need to recognize obscure extra target proteins (e.g. offtargets) of the drug. The second circumstance is that the drug has no known target and we need to anticipate all the potential target proteins of the drug. From the view purpose of the over two functional circumstances, we perform two sorts of crossapprovals: combine astute cross-approval and square shrewd cross-approval. In the match astute cross-approval we played out the accompanying 3-overlap crossapproval. (I) We arbitrarily split drug target matches in the best quality level information into three subsets of generally break even with sizes by combine. (ii) We took every subset as a test set and the staying two subsets as a preparation set. (iii) We prepared a prescient model on the preparation set. (iv) We processed the prediction scores for drug target combines in the test set. (v) Finally, we assessed the prediction exactness over the3-folds.

7 Identification Of Adverse Drug Reaction By Apriori Association Rule Learning 7741 Figure 1: Prediction Models in Block and Pair wise cross Validation In the piece shrewd cross-approval we played out the accompanying 3-overlay crossapproval. (I) We arbitrarily split drugs in the highest quality level information into three drug subsets. (ii) We took each drug subset, and developed a test set of drug target sets from the drug subset and all targets and a preparation set of drug target sets from the staying two drug subsets and all targets. (iii) We prepared a prescient model on the preparation set. (iv) We registered the prediction scores for drug-target matches in the test set. (v) Finally, we assessed the prediction exactness over the 3- folds. Note that lone drugs are part into a preparation set and a test set. Targets are regular crosswise over preparing set and test set. The dataset is partitioned into two preparing datasets with a specific end goal to limit the over-burden are utilized as a part of request to limit the over-burden of the gigantic dataset and to cover the issue in an effective way. Table 1: Prediction Score Pair wise S.No Existing Model Proposed 3- fold model

8 7742 Deepa Lakshmi. K. M and Vijaya M. S. Table 2: Prediction Score Block wise Existing Model Propose 3- fold model Table 3 : Prediction Performance pair wise Increments Existing Threshold proposed Threshold Table 4 : Prediction Accuracy block wise Existing Model Propose 3- fold model Figure 2: Pair wise Prediction Accuracy

9 Identification Of Adverse Drug Reaction By Apriori Association Rule Learning 7743 Figure 3: Pair wise Prediction Score Figure 4: Block Wise Prediction Accuracy Figure 5: Block Wise Prediction Score

10 7744 Deepa Lakshmi. K. M and Vijaya M. S. Figure 6: Overall Prediction Perfomance Calculation Based on Threshold Value There are many drugs that were streamlined from a similar drug lead, so these drugs are synthetically and fundamentally like each other. In the event that these drugs were part into a preparation set and a test set in the cross-approval, the target prediction would be simple, which would overestimate the prediction exactness. To maintain a strategic distance from such an insignificant prediction, we proposed a novel relationship of drugs in light of their concoction structures and utilized just illustrative drugs which are artificially various. In the first place, we played out an Association learning of all drugs in the highest quality level information in light of their compound structure likeness scores. Second, we assembled drugs whose substance structure closeness is more prominent than a limit into a similar group, and we arbitrarily chose just a single drug from each bunch. Third, we developed an arrangement of delegate drugs whose compound structure similitudes were not as much as a limit. At long last, we arranged a few benchmark datasets comprising of just illustrative drugs by changing the limit from 0.1 to 1 by 0.1 addition on the various leveled grouping tree and utilized them to analyze the effect of the edge on prediction execution. Figure 2 to figure 6 shows that the Pair insightful Prediction Accuracy is high in proposed strategy when contrasted with existing technique,the Pair savvy Prediction Score is higher upto 20 % when contrasted and all the current strategies, The Block Wise Prediction Accuracy is extremely exact and effective, when contrasted with the current prediction models, in Figure 5 Block Wise Prediction Score is higher shape 10 to 27 %. The general prediction perfomance Calculation Based on the edge esteem is 15 % to 19%. The general perfomance has been demonstrated that the current techniques needs behind the proposed strategy on a normal of 10% to 15%.

11 Identification Of Adverse Drug Reaction By Apriori Association Rule Learning DISCUSSION AND CONCLUSION This paper talks about the prediction in drug-target communications utilizing AERS. We showed the convenience of our proposed technique to foresee drug target connections that couldn't be normal from drug concoction structures. This demonstrates conceivable favorable circumstances of our strategy when managing pharmaceuticals whose substance structures are not accessible, for example, peptide drugs and rough drug removes whose therapeutically effective fixings are not even now clear. Drug target connections have been explored by an assortment of factual or machine learning strategies with regards to chemogenomics. Most calculations in past chemogenomic techniques can be made relevant to this investigation by supplanting the compound comparability by the pharmacological likeness. Recommending that the proposed calculation beats alternate calculations as far as prediction precision and computational effectiveness. In any case, there would be minimal noteworthy distinction in the inclinations saw in the outcomes on the off chance that we utilized diverse calculations. We demonstrated the estimation of the AERS information for vast scale prediction of drug target collaboration networks. The future change of the prediction strategy would be given by more modern plan of closeness capacities and all around composed content mining systems. For cases, protein similitude in light of ligandrestricting locales and drug side effect comparability in light of the tf-idf measures would be intriguing. Obviously, ceaseless administration and further improvement of the drug databases and additionally the communitarian sharing of learning may add to better prediction of drug target communication networks, conceivably taking care of numerous other pharmaceutical issues. REFERENCES [1]. Rajendra Kumar Roul, Saransh Varshneya, Ashu Kalra, Sanjay Kumar Sahay3. A Novel Modified Apriori Approach for Web Document Clustering [2]. Sardana D, Zhu C, Zhang M, Gudivada RC, Yang L, et al. (2011) Drug repositioning for orphan diseases. Brief Bio inform. [3]. Xie L, Wang J, Bourne PE (2007) Insilico elucidation of the molecular mechanism defining the adverse effect of selective strog enreceptor modulators. PLoS ComputBiol 3:e217. [4]. Campillos M, Kuhn M, Gavin AC, Jensen LJ, Bork P (2008) Drug target identification using side-effect similarity. Science 321: [5]. KeiserMJ,SetolaV,IrwinJJ,LaggnerC,AbbasAI,etal.(2009)Predictingnew molecular targets for known drugs. Nature 462: [6]. YangL,ChenJ,HeL(2009)Harvestingcandidategenesresponsibleforserious adversedrugreactionsfromachemical-proteininteractome.ploscomputbiol

12 7746 Deepa Lakshmi. K. M and Vijaya M. S. 5:e [7]. LuoH,ChenJ,ShiL,MikailovM,ZhuH,etal.(2011)DRAR-CPI:aserverfor identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome. Nucleic AcidsRes. [8]. Yang L, Luo H, Chen J, Xing Q, He L (2009) SePreSA: a server for the prediction of populations susceptible to serious adverse drug reactions implementing the methodology of a chemical-protein interactome. Nucleic Acids Res 37:W [9]. Wallach I, Jaitly N, Lilien R (2010) A structure-based approach for mapping adverse drug reactions to the perturbation of underlying biological pathways. PLoS One 5:e [10]. Suthram S, Dudley JT, Chiang AP, Chen R, Hastie TJ, et al. (2010) Network- based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets. PLoS ComputBiol 6:e [11]. YangL,WangK,ChenJ,JeggaAG,LuoH,etal.(2011)Exploringoff-targetsand off-systems for adverse drug reactions via chemical-protein interactome clozapine- inducedagranulocytosis as a case study. PLoSComputBiol7:e [12]. Iorio F, Bosotti R, Scacheri E, Belcastro V, Mithbaokar P, et al. (2010) Discovery of drug mode of action and drug repositioning from transcriptional responses. ProcNatlAcadSci U S A 107: [13]. Hu G, Agarwal P (2009) Human disease-drug network based on genomic expression profiles. PLoS One 4:e6536. [14]. PouliotY,ChiangAP,ButteAJ(2011)PredictingAdverseDrugReactionsUsing Publicly Available PubChemBioAssay Data. ClinPharmacolTher 90: [15]. Tatonetti NP, Denny JC, Murphy SN, Fernald GH, Krishnan G, et al. (2011) Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels. Clin Pharmacol Ther 90: [16]. Buchan NS, Rajpal DK, Webster Y, Alatorre C, Gudivada RC, et al. (2011)The role of translational bioinformatics in drug discovery. Drug Discov Today 16: [17]. Swinney DC, Anthony J (2011) How were new medicines discovered? Nat Rev Drug Discov 10:

13 Identification Of Adverse Drug Reaction By Apriori Association Rule Learning 7747 [18]. Chiang AP, Butte AJ (2009) Systematic evaluation of drug-disease relationships to identify leads for novel drug uses. ClinPharmacolTher 86: [19]. Altman RB(2007)Pharm GKB: a logical home for knowledge relating genotype to drug response phenotype. Nat Genet 39:426. [20]. Yang L, Xu L, He L (2009) A Citation Rank algorithm inheriting Google technology designed to highlight genes responsible for serious adverse drug reaction. Bioinformatics 25: [21]. Vogelgesang A, Dressel A (2011) Immunological consequences of ischemic stroke: immunosuppression and autoimmunity. J Neuroimmunol 231: [22]. O Regan C, Wu P, Arora P, Perri D, Mills EJ (2008) Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients. Am J Med 121: [23]. Bosch J, Yusuf S, Pogue J, Sleight P, Lonn E, et al. (2002) Use of ramipril in preventing stroke: double blind randomised trial. BMJ 324: [24]. Dechanet J, Merville P, Berge F, Bone-Mane G, Taupin JL, et al. (1999) Major expansion of gamma delta Tlymphocytes following cytomegalo virus infection in kidney allograft recipients. J Infect Dis 179:1 8. [25]. Sun RC, Shek DT, SiuAM (2008) Positive school and classroom environment: precursors of successful implementation of positive youth development programs. Scientific World Journal 8: [26]. AnderssonC,BylesjoI, LithnerF(1999)Effects of diabetes mellitus on patients with acute intermittent porphyria. J Intern Med 245: [27]. Terasmaa A, Soomets U, Oflijan J, Punapart M, Hansen M, et al. (2011) Wfs1 mutation makes mice sensitive to insulin-like effect of acute valproic acid and resistant to streptozocin. J Physiol Biochem. [28]. Nijland HM, Ruslami R, Stalenhoef JE, Nelwan EJ, Alisjahbana B, et al. (2006) Exposure torifampicinis strongly reduced in patients with tuberculosis and type 2 diabetes. Clin Infect Dis 43: [29]. Kendig EL, Schneider SN, Clegg DJ, Genter MB, Shertzer HG (2008) Over- the-counter analgesics normalize blood glucose and body composition in mice fed a high fat diet. Biochem Pharmacol 76:

14 7748 Deepa Lakshmi. K. M and Vijaya M. S.

PREDICTING PREVENTABLE ADVERSE EVENTS USING INTEGRATED SYSTEMS PHARMACOLOGY

PREDICTING PREVENTABLE ADVERSE EVENTS USING INTEGRATED SYSTEMS PHARMACOLOGY PREDICTING PREVENTABLE ADVERSE EVENTS USING INTEGRATED SYSTEMS PHARMACOLOGY GUY HASKIN FERNALD 1, DORNA KASHEF 2, NICHOLAS P. TATONETTI 1 Center for Biomedical Informatics Research 1, Department of Computer

More information

Genetic Resources & Drug Discovery: View from Informatics

Genetic Resources & Drug Discovery: View from Informatics Genetic Resources & Drug Discovery: View from Informatics Russ B. Altman, MD, PhD Departments of Bioengineering, Genetics, Medicine & (by courtesy) Computer Science Stanford University PharmGKB, http://www.pharmgkb.org/

More information

- OMICS IN PERSONALISED MEDICINE

- OMICS IN PERSONALISED MEDICINE SUMMARY REPORT - OMICS IN PERSONALISED MEDICINE Workshop to explore the role of -omics in the development of personalised medicine European Commission, DG Research - Brussels, 29-30 April 2010 Page 2 Summary

More information

3.1 Publishable summary

3.1 Publishable summary 3.1 Publishable summary This section must be of suitable quality to enable direct publication by the Commission. A summary description of project context and objectives, 4000 characters max The central

More information

Our website:

Our website: Biomedical Informatics Summer Internship Program (BMI SIP) The Department of Biomedical Informatics hosts an annual internship program each summer which provides high school, undergraduate, and graduate

More information

Gene expression connectivity mapping and its application to Cat-App

Gene expression connectivity mapping and its application to Cat-App Gene expression connectivity mapping and its application to Cat-App Shu-Dong Zhang Northern Ireland Centre for Stratified Medicine University of Ulster Outline TITLE OF THE PRESENTATION Gene expression

More information

Testimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association

Testimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association Testimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association Before the House Energy and Commerce Subcommittee on Health 21st Century Cures: Examining the Regulation of Laboratory

More information

Bioinformatics : Gene Expression Data Analysis

Bioinformatics : Gene Expression Data Analysis 05.12.03 Bioinformatics : Gene Expression Data Analysis Aidong Zhang Professor Computer Science and Engineering What is Bioinformatics Broad Definition The study of how information technologies are used

More information

INSTRUCTIONS FOR COMPLETION OF THE CCAC ANIMAL USE DATA FORM

INSTRUCTIONS FOR COMPLETION OF THE CCAC ANIMAL USE DATA FORM INSTRUCTIONS FOR COMPLETION THE CCAC ANIMAL USE DATA FORM TABLE CONTENTS 1. PREAMBLE... 1 2. INTRODUCTION... 1 3. TO BE INCLUDED ON THE AUDF... 2 4. REQUIRED ELEMENTS... 2 1. Unique Protocol Number...

More information

A Protein Secondary Structure Prediction Method Based on BP Neural Network Ru-xi YIN, Li-zhen LIU*, Wei SONG, Xin-lei ZHAO and Chao DU

A Protein Secondary Structure Prediction Method Based on BP Neural Network Ru-xi YIN, Li-zhen LIU*, Wei SONG, Xin-lei ZHAO and Chao DU 2017 2nd International Conference on Artificial Intelligence: Techniques and Applications (AITA 2017 ISBN: 978-1-60595-491-2 A Protein Secondary Structure Prediction Method Based on BP Neural Network Ru-xi

More information

Changing Mutation Operator of Genetic Algorithms for optimizing Multiple Sequence Alignment

Changing Mutation Operator of Genetic Algorithms for optimizing Multiple Sequence Alignment International Journal of Information and Computation Technology. ISSN 0974-2239 Volume 3, Number 11 (2013), pp. 1155-1160 International Research Publications House http://www. irphouse.com /ijict.htm Changing

More information

The Role of Adult Stem Cells in Personalized and Regenerative Medicine

The Role of Adult Stem Cells in Personalized and Regenerative Medicine The Role of Adult Stem Cells in Personalized and Regenerative Medicine Christopher J. Neill, Director of Corporate Operations American CryoStem Corporation Objective To illustrate the potential benefits

More information

How Targets Are Chosen. Chris Wayman 12 th April 2012

How Targets Are Chosen. Chris Wayman 12 th April 2012 How Targets Are Chosen Chris Wayman 12 th April 2012 A few questions How many ideas does it take to make a medicine? 10 20 20-50 50-100 A few questions How long does it take to bring a product from bench

More information

Biomedical Sciences Graduate Program

Biomedical Sciences Graduate Program 1 of 6 Graduate School 250 University Hall 230 North Oval Mall Columbus, OH 43210-1366 January 11, 2013 Phone (614) 292-6031 Fax (614) 292-3656 Jeff Parvin, Joanna Groden Co-Graduate Studies Chairs Biomedical

More information

Recent years have witnessed an expansion in the disciplines encompassing drug

Recent years have witnessed an expansion in the disciplines encompassing drug Course overview Recent years have witnessed an expansion in the disciplines encompassing drug discovery outside the pharmaceutical industry. This is most notable with a significant number of Universities

More information

Pharmacogenetics of Drug-Induced Side Effects

Pharmacogenetics of Drug-Induced Side Effects Pharmacogenetics of Drug-Induced Side Effects Hui - Ching Huang Department of Pharmacy, Yuli Hospital DOH Department of Pharmacology, Tzu Chi University April 20, 2013 Brief history of HGP 1953: DNA

More information

Following text taken from Suresh Kumar. Bioinformatics Web - Comprehensive educational resource on Bioinformatics. 6th May.2005

Following text taken from Suresh Kumar. Bioinformatics Web - Comprehensive educational resource on Bioinformatics. 6th May.2005 Bioinformatics is the recording, annotation, storage, analysis, and searching/retrieval of nucleic acid sequence (genes and RNAs), protein sequence and structural information. This includes databases of

More information

The Interaction-Interaction Model for Disease Protein Discovery

The Interaction-Interaction Model for Disease Protein Discovery The Interaction-Interaction Model for Disease Protein Discovery Ken Cheng December 10, 2017 Abstract Network medicine, the field of using biological networks to develop insight into disease and medicine,

More information

PREDICTING EMPLOYEE ATTRITION THROUGH DATA MINING

PREDICTING EMPLOYEE ATTRITION THROUGH DATA MINING PREDICTING EMPLOYEE ATTRITION THROUGH DATA MINING Abbas Heiat, College of Business, Montana State University, Billings, MT 59102, aheiat@msubillings.edu ABSTRACT The purpose of this study is to investigate

More information

Application of Deep Learning to Drug Discovery

Application of Deep Learning to Drug Discovery Application of Deep Learning to Drug Discovery Hiroshi Tanaka Tohoku Medical Megabank Orga nization, Tohoku University Current Situation of Drug Discovery Rapid increase of R&D expenditure More than 1B

More information

Introduction to Bioinformatics

Introduction to Bioinformatics Introduction to Bioinformatics If the 19 th century was the century of chemistry and 20 th century was the century of physic, the 21 st century promises to be the century of biology...professor Dr. Satoru

More information

BIOINFORMATICS AND SYSTEM BIOLOGY (INTERNATIONAL PROGRAM)

BIOINFORMATICS AND SYSTEM BIOLOGY (INTERNATIONAL PROGRAM) BIOINFORMATICS AND SYSTEM BIOLOGY (INTERNATIONAL PROGRAM) PROGRAM TITLE DEGREE TITLE Master of Science Program in Bioinformatics and System Biology (International Program) Master of Science (Bioinformatics

More information

A Propagation-based Algorithm for Inferring Gene-Disease Associations

A Propagation-based Algorithm for Inferring Gene-Disease Associations A Propagation-based Algorithm for Inferring Gene-Disease Associations Oron Vanunu Roded Sharan Abstract: A fundamental challenge in human health is the identification of diseasecausing genes. Recently,

More information

Introduction to Drug Design and Discovery

Introduction to Drug Design and Discovery Introduction to Drug Design and Discovery Course: Drug Design Course code: 0510412 Dr. Balakumar Chandrasekaran Dr. Bilal Al-Jaidi Assistant Professors, Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy,

More information

Feature Selection of Gene Expression Data for Cancer Classification: A Review

Feature Selection of Gene Expression Data for Cancer Classification: A Review Available online at www.sciencedirect.com ScienceDirect Procedia Computer Science 50 (2015 ) 52 57 2nd International Symposium on Big Data and Cloud Computing (ISBCC 15) Feature Selection of Gene Expression

More information

2. Materials and Methods

2. Materials and Methods Identification of cancer-relevant Variations in a Novel Human Genome Sequence Robert Bruggner, Amir Ghazvinian 1, & Lekan Wang 1 CS229 Final Report, Fall 2009 1. Introduction Cancer affects people of all

More information

You ve Got the POWER! What You Should Know About Clinical Trials

You ve Got the POWER! What You Should Know About Clinical Trials You ve Got the POWER! What You Should Know About Clinical Trials Project I.M.P.A.C.T. (Increase Minority Participation and Awareness of Clinical Trials) We want to help you and your family use medical

More information

Pharmacogenetics: A SNPshot of the Future. Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001

Pharmacogenetics: A SNPshot of the Future. Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001 Pharmacogenetics: A SNPshot of the Future Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001 1 I. What is pharmacogenetics? It is the study of how genetic variation affects drug response

More information

CHALLENGES AND OPPORTUNITIES ON FORMULATION AND DEVELOPMENT OF FIXED DOSE COMBINATIONS: UNIGEL, A TECHNOLOGICAL PLATFORM

CHALLENGES AND OPPORTUNITIES ON FORMULATION AND DEVELOPMENT OF FIXED DOSE COMBINATIONS: UNIGEL, A TECHNOLOGICAL PLATFORM CHALLENGES AND OPPORTUNITIES ON FORMULATION AND DEVELOPMENT OF FIXED DOSE COMBINATIONS: UNIGEL, A TECHNOLOGICAL PLATFORM CLAUDIA SILVA, IVAN ROMERO, DIEGO MONTERROZA. PROCAPS S.A ABSTRACT This article

More information

An Analytical Upper Bound on the Minimum Number of. Recombinations in the History of SNP Sequences in Populations

An Analytical Upper Bound on the Minimum Number of. Recombinations in the History of SNP Sequences in Populations An Analytical Upper Bound on the Minimum Number of Recombinations in the History of SNP Sequences in Populations Yufeng Wu Department of Computer Science and Engineering University of Connecticut Storrs,

More information

Alexander Statnikov, Ph.D.

Alexander Statnikov, Ph.D. Alexander Statnikov, Ph.D. Director, Computational Causal Discovery Laboratory Benchmarking Director, Best Practices Integrative Informatics Consultation Service Assistant Professor, Department of Medicine,

More information

Using DeMAND, a package for Interrogating Drug Mechanism of Action using Network Dysregulation analysis

Using DeMAND, a package for Interrogating Drug Mechanism of Action using Network Dysregulation analysis Using DeMAND, a package for Interrogating Drug Mechanism of Action using Network Dysregulation analysis Jung Hoon Woo, Yishai Shimoni, Mukesh Bansal, and Andrea Califano Columbia University, New York,

More information

Application of Deep Learning to Drug Discovery

Application of Deep Learning to Drug Discovery Application of Deep Learning to Drug Discovery Hase T, Tsuji S, Shimokawa K, Tanaka H Tohoku Medical Megabank Organization, Tohoku University Current Situation of Drug Discovery Rapid increase of R&D expenditure

More information

PREDICTING SAFETY INFORMATION OF DRUGS USING DATA MINING TECHNIQUE

PREDICTING SAFETY INFORMATION OF DRUGS USING DATA MINING TECHNIQUE International Journal of Computer Engineering & Technology (IJCET) Volume 10, Issue 2, March April, 2019, pp. 83-90. Article ID: IJCET_10_02_010 Available online at http://www.iaeme.com/ijcet/issues.asp?jtype=ijcet&vtype=10&itype=2

More information

Clinical studies. BARBORA VLKOVÁ INSTITUTE OF MOLECULAR BIOMEDICINE

Clinical studies. BARBORA VLKOVÁ INSTITUTE OF MOLECULAR BIOMEDICINE Clinical studies BARBORA VLKOVÁ INSTITUTE OF MOLECULAR BIOMEDICINE www.imbm.sk barboravlk@gmail.com Biomedical research 1. Basic research a. In vitro = cell cultures b. In vivo = experimental animals c.

More information

Course Agenda. Day One

Course Agenda. Day One Course Agenda BioImmersion: Biotech for the Non-Scientist A three-day, in-depth course that provides the background required for understanding today s fast-paced biotech marketplace. Beginning with an

More information

Assembly Biosciences Jefferies 2015 Microbiome Summit. December 16, 2015

Assembly Biosciences Jefferies 2015 Microbiome Summit. December 16, 2015 Assembly Biosciences Jefferies 2015 Microbiome Summit December 16, 2015 Forward-Looking Statements This presentation contains forward-looking statements regarding future events. Forward-looking statements

More information

Finding Compensatory Pathways in Yeast Genome

Finding Compensatory Pathways in Yeast Genome Finding Compensatory Pathways in Yeast Genome Olga Ohrimenko Abstract Pathways of genes found in protein interaction networks are used to establish a functional linkage between genes. A challenging problem

More information

International Journal of Computer Science Trends and Technology (IJCST) Volume 2 Issue 1, Jan-Feb 2014

International Journal of Computer Science Trends and Technology (IJCST) Volume 2 Issue 1, Jan-Feb 2014 Heart Disease Prediction Using the Data mining Techniques Aswathy Wilson 1, Gloria Wilson 2, Likhiya Joy K 3 Professor 1, Department of Computer Science and Engineering Jyothi Engineering College, Cheruthuruthy,

More information

COMPUTER AIDED DRUG DESIGN: AN OVERVIEW

COMPUTER AIDED DRUG DESIGN: AN OVERVIEW Available online on 19.09.2018 at http://jddtonline.info Journal of Drug Delivery and Therapeutics Open Access to Pharmaceutical and Medical Research 2011-18, publisher and licensee JDDT, This is an Open

More information

PROFITABLE ITEMSET MINING USING WEIGHTS

PROFITABLE ITEMSET MINING USING WEIGHTS PROFITABLE ITEMSET MINING USING WEIGHTS T.Lakshmi Surekha 1, Ch.Srilekha 2, G.Madhuri 3, Ch.Sujitha 4, G.Kusumanjali 5 1Assistant Professor, Department of IT, VR Siddhartha Engineering College, Andhra

More information

The role of genomics in the development of new and improved therapies

The role of genomics in the development of new and improved therapies The role of genomics in the development of new and improved therapies An appreciation of the importance of genetic diversity will have a profound impact on how drugs are discovered, developed and prescribed.

More information

Vision, aims and strategies. Department of Immunology, Genetics and Pathology Uppsala University

Vision, aims and strategies. Department of Immunology, Genetics and Pathology Uppsala University Vision, aims and strategies Department of Immunology, Genetics and Pathology Uppsala University April19,2011 SCOPEOFACTIVITIESATIGP Research at the Department focuses on translational medicine through

More information

Case Study: Dr. Jonny Wray, Head of Discovery Informatics at e-therapeutics PLC

Case Study: Dr. Jonny Wray, Head of Discovery Informatics at e-therapeutics PLC Reaxys DRUG DISCOVERY & DEVELOPMENT Case Study: Dr. Jonny Wray, Head of Discovery Informatics at e-therapeutics PLC Clean compound and bioactivity data are essential to successful modeling of the impact

More information

The Need for National Pharmacovigilance Program

The Need for National Pharmacovigilance Program The Need for National Pharmacovigilance Program ANAS BAHNASSI Presented at Order of Lebanese Pharmacists on March 10 th 2018 All drugs are dangerous Some are also useful. N. Moore, BMJ, 2005, 330;539-540

More information

Design and Development of Efficient Drug Reposition Scheme with Probabilistic Kernel based Text Mining Classification Model

Design and Development of Efficient Drug Reposition Scheme with Probabilistic Kernel based Text Mining Classification Model Design and Development of Efficient Drug Reposition Scheme with Probabilistic Kernel based Text Mining Classification Model P. Jyotsna 1, Dr. P. Govindarajulu 2 Research Scholar, Department of Computer

More information

TEXT MINING FOR BONE BIOLOGY

TEXT MINING FOR BONE BIOLOGY Andrew Hoblitzell, Snehasis Mukhopadhyay, Qian You, Shiaofen Fang, Yuni Xia, and Joseph Bidwell Indiana University Purdue University Indianapolis TEXT MINING FOR BONE BIOLOGY Outline Introduction Background

More information

Volunteering for Clinical Trials

Volunteering for Clinical Trials Volunteering for Clinical Trials Volunteering for Clinical Trials When considering volunteering for a clinical trial, it is important to make an informed decision. Below are answers to frequently asked

More information

CONCEPT OF SIMILAR MEDICINAL PRODUCT IN THE CONTEXT OF THE ORPHAN LEGISLATION: ADAPTATION TO TECHNICAL PROGRESS

CONCEPT OF SIMILAR MEDICINAL PRODUCT IN THE CONTEXT OF THE ORPHAN LEGISLATION: ADAPTATION TO TECHNICAL PROGRESS Ref. Ares(2016)6257284-04/11/2016 04 November 2016 Submission of comments on the Consultation Document CONCEPT OF SIMILAR MEDICINAL PRODUCT IN THE CONTEXT OF THE ORPHAN LEGISLATION: ADAPTATION TO TECHNICAL

More information

Data mining: Identify the hidden anomalous through modified data characteristics checking algorithm and disease modeling By Genomics

Data mining: Identify the hidden anomalous through modified data characteristics checking algorithm and disease modeling By Genomics Data mining: Identify the hidden anomalous through modified data characteristics checking algorithm and disease modeling By Genomics PavanKumar kolla* kolla.haripriyanka+ *School of Computing Sciences,

More information

This place covers: Methods or systems for genetic or protein-related data processing in computational molecular biology.

This place covers: Methods or systems for genetic or protein-related data processing in computational molecular biology. G16B BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY Methods or systems for genetic

More information

- Selection of Target Molecular for Drug Discovery by Verifications on the Validity of Target Candidates -

- Selection of Target Molecular for Drug Discovery by Verifications on the Validity of Target Candidates - University of Tokyo and Astellas Enter Collaborative Research for Target Discovery of New Drugs for Neglected Tropical Diseases Caused by Protozoan Parasites - Selection of Target Molecular for Drug Discovery

More information

The interactions that occur between two proteins are essential parts of biological systems.

The interactions that occur between two proteins are essential parts of biological systems. Gabor 1 Evaluation of Different Biological Data and Computational Classification Methods for Use in Protein Interaction Prediction in Signaling Pathways in Humans Yanjun Qi 1 and Judith Klein-Seetharaman

More information

Systematic Drug Repositioning Based on Clinical Side- Effects

Systematic Drug Repositioning Based on Clinical Side- Effects Systematic Drug Repositioning Based on Clinical Side- Effects Lun Yang*, Pankaj Agarwal Computational Biology, Quantitative Sciences, Medicines Discovery and Development, GlaxoSmithKline, Philadelphia,

More information

Practice Exam A. Briefly describe how IL-25 treatment might be able to help this responder subgroup of liver cancer patients.

Practice Exam A. Briefly describe how IL-25 treatment might be able to help this responder subgroup of liver cancer patients. Practice Exam 2007 1. A special JAK-STAT signaling system (JAK5-STAT5) was recently identified in which a gene called TS5 becomes selectively transcribed and expressed in the liver upon induction by a

More information

Drug Development: Why Does it Cost so Much? Lewis J. Smith, MD Professor of Medicine Director, Center for Clinical Research Associate VP for Research

Drug Development: Why Does it Cost so Much? Lewis J. Smith, MD Professor of Medicine Director, Center for Clinical Research Associate VP for Research Drug Development: Why Does it Cost so Much? Lewis J. Smith, MD Professor of Medicine Director, Center for Clinical Research Associate VP for Research Drug Development Process by which new chemical entities

More information

Introduction to Pharmacogenomics

Introduction to Pharmacogenomics Introduction to Pharmacogenomics Ching-Lung Cheung, PhD Assistant Professor, Department of Pharmacology and Pharmacy, Centre for Genomic Sciences, HKU Overview of the lecture Overview of the lecture Introduction

More information

First Place Essay. Katie P.

First Place Essay. Katie P. First Place Essay Katie P. Eighth Grade West Reading, PA 19611 Bioscience research is seeking information by exploring life's processes and diseases. It has helped many scientists understand how the body

More information

Polypharmacology. Giulio Rastelli Molecular Modelling and Drug Design Lab

Polypharmacology. Giulio Rastelli Molecular Modelling and Drug Design Lab Polypharmacology Giulio Rastelli Molecular Modelling and Drug Design Lab www.mmddlab.unimore.it Dipartimento di Scienze della Vita Università di Modena e Reggio Emilia giulio.rastelli@unimore.it Magic

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION Box S1 Data and analysis Sample construction New molecular entities and novel biologics hereafter novel therapeutics approved by the US Food and Drug Administration (FDA) between January 1, 2005 and December

More information

Capabilities & Services

Capabilities & Services Capabilities & Services Accelerating Research & Development Table of Contents Introduction to DHMRI 3 Services and Capabilites: Genomics 4 Proteomics & Protein Characterization 5 Metabolomics 6 In Vitro

More information

From Bench to Bedside: Role of Informatics. Nagasuma Chandra Indian Institute of Science Bangalore

From Bench to Bedside: Role of Informatics. Nagasuma Chandra Indian Institute of Science Bangalore From Bench to Bedside: Role of Informatics Nagasuma Chandra Indian Institute of Science Bangalore Electrocardiogram Apparent disconnect among DATA pieces STUDYING THE SAME SYSTEM Echocardiogram Chest sounds

More information

STRAND NGS 3.0 ALLOWS USERS TO ANALYZE DATA AT NEARLY TWICE THE SPEED

STRAND NGS 3.0 ALLOWS USERS TO ANALYZE DATA AT NEARLY TWICE THE SPEED bio chat STRAND NGS 3.0 ALLOWS USERS TO ANALYZE DATA AT NEARLY TWICE THE SPEED The Bangalore based Strand Life Sciences has been recently in news for the back to back launch of two innovative products.

More information

Bayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms

Bayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms Bayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms Genomics Bioinformatics HTS Combinatorial chemistry Protein drugs

More information

Recommendation on elements required to support the medical plausibility and the assumption of significant benefit for an orphan designation

Recommendation on elements required to support the medical plausibility and the assumption of significant benefit for an orphan designation 2 March 2010 EMA/COMP/15893/2009 Final Committee for Orphan Medicinal Products (COMP) Recommendation on elements required to support the medical plausibility and the assumption of significant benefit for

More information

In silico prediction of novel therapeutic targets using gene disease association data

In silico prediction of novel therapeutic targets using gene disease association data In silico prediction of novel therapeutic targets using gene disease association data, PhD, Associate GSK Fellow Scientific Leader, Computational Biology and Stats, Target Sciences GSK Big Data in Medicine

More information

Malaria Research Capability Strengthening in Africa

Malaria Research Capability Strengthening in Africa July 2005 UNICEF/UNDP/World Bank/WHO Special Programme for Research & Training in Tropical Diseases (TDR) Multilateral Initiative on Malaria (MIM) Malaria Research Capability Strengthening in Africa INTRODUCTION

More information

Design and Implementation of Office Automation System based on Web Service Framework and Data Mining Techniques. He Huang1, a

Design and Implementation of Office Automation System based on Web Service Framework and Data Mining Techniques. He Huang1, a 3rd International Conference on Materials Engineering, Manufacturing Technology and Control (ICMEMTC 2016) Design and Implementation of Office Automation System based on Web Service Framework and Data

More information

The NHS approach to personalised medicine in respiratory disease. Professor Sue Chief Scientific Officer for England

The NHS approach to personalised medicine in respiratory disease. Professor Sue Chief Scientific Officer for England The NHS approach to personalised medicine in respiratory disease Professor Sue Hill @CSOSue Chief Scientific Officer for England Jul 2017 Genomics is probably the biggest breakthrough in the last 50 years.

More information

Feature Articles: Software Development Technologies

Feature Articles: Software Development Technologies Feature Articles: Software Development Technologies Research and development Software Development Standards and their Operations Abstract The Augmatiks Service Innovation Laboratories has made special

More information

Advancing Manufacturing for Advanced Therapies

Advancing Manufacturing for Advanced Therapies Advancing Manufacturing for Advanced Therapies Peter Marks, MD, PhD Center For Biologics Evaluation and Research, FDA CASSS Cell & Gene Therapy Symposium July 10, 2018 Overview Cell and gene therapy products

More information

Solving Drug Enzyme-Target Identification Problem Using Genetic Algorithm

Solving Drug Enzyme-Target Identification Problem Using Genetic Algorithm The Second International Symposium on Optimization and Systems Biology (OSB 08) Lijiang, China, October 31 November 3, 2008 Copyright 2008 ORSC & APORC, pp. 375 380 Solving Drug Enzyme-Target Identification

More information

Software Risk Management and Risk Mitigation Technique

Software Risk Management and Risk Mitigation Technique Software Risk Management and Risk Mitigation Technique Kunal Deswal 1 & Shweta Thakur 2 Student, Dept. of Information Technology. DCE, Gurgaon, Harayana, India ABSTRACT Software Engineering is the craft

More information

Update on the IVDR. Sue Spencer

Update on the IVDR. Sue Spencer Update on the IVDR Sue Spencer Caution The new regulations are draft the principles have now been agreed but the Annexes are subject to minor changes Further details will be added later pre and post application

More information

Bioinformatics Specialist

Bioinformatics Specialist Bioinformatics Specialist At a Glance Bioinformatics specialists use their knowledge of computers and math to collect, analyze, and store biological data. Search by Cluster Computers & Telecom Science

More information

Analysis of Associative Classification for Prediction of HCV Response to Treatment

Analysis of Associative Classification for Prediction of HCV Response to Treatment International Journal of Computer Applications (975 8887) Analysis of Associative Classification for Prediction of HCV Response to Treatment Enas M.F. El Houby Systems & Information Dept., Engineering

More information

Trend in diagnostic biochip. Eiichiro Ichiishi, M.D., Ph.D. Department of Internal Medicine International University of Health and Welfare Hospital

Trend in diagnostic biochip. Eiichiro Ichiishi, M.D., Ph.D. Department of Internal Medicine International University of Health and Welfare Hospital Trend in diagnostic biochip development Eiichiro Ichiishi, M.D., Ph.D. Department of Internal Medicine International University of Health and Welfare Hospital Handling of the early stage is important for

More information

Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality

Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality Hua Xu, PhD School of Biomedical Informatics, UTHealth JAMIA Journal

More information

Brain Tumour Australia Information FACT SHEET 22 Clinical Trials: Questions and Answers

Brain Tumour Australia Information FACT SHEET 22 Clinical Trials: Questions and Answers FACT SHEET 22 Clinical Trials: Questions and Answers What is a clinical trial? Clinical trials are research studies that answer scientific questions and try to find better ways to prevent, screen for,

More information

An Evolutionary Optimization for Multiple Sequence Alignment

An Evolutionary Optimization for Multiple Sequence Alignment 195 An Evolutionary Optimization for Multiple Sequence Alignment 1 K. Lohitha Lakshmi, 2 P. Rajesh 1 M tech Scholar Department of Computer Science, VVIT Nambur, Guntur,A.P. 2 Assistant Prof Department

More information

The Function Transformation Omics Funomics. There are no two identical leaves in the world, so how to find effective

The Function Transformation Omics Funomics. There are no two identical leaves in the world, so how to find effective The Function Transformation Omics Funomics Yongshuai Jiang 1,* Jing Xu 1, Simeng Hu 1, Di Liu 1, Linna Zhao 1, Xu Zhou 1 1.College of Bioinformatics Science and Technology, Harbin Medical University, Harbin,

More information

OMICS Group. Contact us at:

OMICS Group. Contact us at: OMICS Group OMICS Group International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Group hosts over 400 leading-edge peer

More information

Towards Personalized Medicine: Leveraging Patient Similarity and Drug Similarity Analytics

Towards Personalized Medicine: Leveraging Patient Similarity and Drug Similarity Analytics Towards Personalized Medicine: Leveraging Patient Similarity and Drug Similarity Analytics Ping Zhang, Fei Wang, Jianying Hu, Robert Sorrentino Healthcare Analytics Research Group IBM T.J. Watson Research

More information

Introducing the Department of Life Sciences

Introducing the Department of Life Sciences Introducing the Department of Life Sciences Life Sciences is a discipline that aims at a fundamental understanding of life phenomena by exploring complex and mysterious structures and funct ions of living

More information

fact sheet 3 Introduction to Biosimilars & Regulatory Requirements

fact sheet 3 Introduction to Biosimilars & Regulatory Requirements 3 fact sheet 3 Introduction to Biosimilars & Regulatory Requirements International Alliance of Patients Organizations CAN Mezzanine 49-51 East Road London N1 6AH United Kingdom International Federation

More information

Drug Targets - an overview of historical success and protein kinase inhibitors - successes and attrition. John P. Overington

Drug Targets - an overview of historical success and protein kinase inhibitors - successes and attrition. John P. Overington Drug Targets - an overview of historical success and protein kinase inhibitors - successes and attrition John P. Overington jpo@ebi.ac.uk Assay/Target ChEMBL The Organisation of Drug Discovery 1. Scientific

More information

Computational Genomics. Reconstructing signaling and dynamic regulatory networks

Computational Genomics. Reconstructing signaling and dynamic regulatory networks 02-710 Computational Genomics Reconstructing signaling and dynamic regulatory networks Input Output Hidden Markov Model Input (Static transcription factorgene interactions) Bengio and Frasconi, NIPS 1995

More information

trial. Key trial data points:

trial. Key trial data points: February 23, 2015 ADMA Biologics Announces Positive Data on Primary and Secondary Endpoints from its Pivotal Phase III Clinical Trial for RI-002 at the AAAAI Medical Conference RAMSEY, N.J., Feb. 23, 2015

More information

Genetics and Genomics in Medicine Chapter 9 Questions

Genetics and Genomics in Medicine Chapter 9 Questions Genetics and Genomics in Medicine Chapter 9 Questions Multiple Choice Questions Question 9.1 Which, if any, of the following can be classified as a type of augmentation therapy? a) Treatment using a small

More information

Workshop on flexible designs for diagnostic studies. from diagnostic accuracy to personalized medicine

Workshop on flexible designs for diagnostic studies. from diagnostic accuracy to personalized medicine Workshop on flexible designs for diagnostic studies from diagnostic accuracy to personalized medicine Structure Background Sources of error Summary 06/11/2017 Introduction 2 Structure Background Sources

More information

From genome-wide association studies to disease relationships. Liqing Zhang Department of Computer Science Virginia Tech

From genome-wide association studies to disease relationships. Liqing Zhang Department of Computer Science Virginia Tech From genome-wide association studies to disease relationships Liqing Zhang Department of Computer Science Virginia Tech Types of variation in the human genome ( polymorphisms SNPs (single nucleotide Insertions

More information

A STUDY ON STATISTICAL BASED FEATURE SELECTION METHODS FOR CLASSIFICATION OF GENE MICROARRAY DATASET

A STUDY ON STATISTICAL BASED FEATURE SELECTION METHODS FOR CLASSIFICATION OF GENE MICROARRAY DATASET A STUDY ON STATISTICAL BASED FEATURE SELECTION METHODS FOR CLASSIFICATION OF GENE MICROARRAY DATASET 1 J.JEYACHIDRA, M.PUNITHAVALLI, 1 Research Scholar, Department of Computer Science and Applications,

More information

Application of Decision Trees in Mining High-Value Credit Card Customers

Application of Decision Trees in Mining High-Value Credit Card Customers Application of Decision Trees in Mining High-Value Credit Card Customers Jian Wang Bo Yuan Wenhuang Liu Graduate School at Shenzhen, Tsinghua University, Shenzhen 8, P.R. China E-mail: gregret24@gmail.com,

More information

SSPPS STRATEGIC PLAN. Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice. April 30, Overview

SSPPS STRATEGIC PLAN. Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice. April 30, Overview SSPPS STRATEGIC PLAN Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice April 30, 2012 Overview Here we present the 2012-2017 strategic plan for the Skaggs School of Pharmacy

More information

BIOINFORMATICS THE MACHINE LEARNING APPROACH

BIOINFORMATICS THE MACHINE LEARNING APPROACH 88 Proceedings of the 4 th International Conference on Informatics and Information Technology BIOINFORMATICS THE MACHINE LEARNING APPROACH A. Madevska-Bogdanova Inst, Informatics, Fac. Natural Sc. and

More information

Drug Discovery in Chemoinformatics Using Adaptive Neuro-Fuzzy Inference System

Drug Discovery in Chemoinformatics Using Adaptive Neuro-Fuzzy Inference System Drug Discovery in Chemoinformatics Using Adaptive Neuro-Fuzzy Inference System Kirti Kumari Dixit 1, Dr. Hitesh B. Shah 2 1 Information Technology, G.H.Patel College of Engineering, dixit.mahi@gmail.com

More information

Analysis of Hot Points on Data Mining Research of Medical in Foreign Countries

Analysis of Hot Points on Data Mining Research of Medical in Foreign Countries Cross-Cultural Communication Vol. 12, No., 216, pp. 1-5 DOI:.6/722 ISSN 1712-5[Print] ISSN 12-67[Online] www.cscanada.net www.cscanada.org Analysis of Hot Points on Data Mining Research of Medical in Foreign

More information

Identification of biological themes in microarray data from a mouse heart development time series using GeneSifter

Identification of biological themes in microarray data from a mouse heart development time series using GeneSifter Identification of biological themes in microarray data from a mouse heart development time series using GeneSifter VizX Labs, LLC Seattle, WA 98119 Abstract Oligonucleotide microarrays were used to study

More information

Solving the Problem of New Uses

Solving the Problem of New Uses Solving the Problem of New Uses Benjamin Roin, Harvard Law School benroin@law.harvard.edu Presented at Duke Law School Center for Innovation Policy s New Approaches and Incentives in Drug Development,

More information

advanced analysis of gene expression microarray data aidong zhang World Scientific State University of New York at Buffalo, USA

advanced analysis of gene expression microarray data aidong zhang World Scientific State University of New York at Buffalo, USA advanced analysis of gene expression microarray data aidong zhang State University of New York at Buffalo, USA World Scientific NEW JERSEY LONDON SINGAPORE BEIJING SHANGHAI HONG KONG TAIPEI CHENNAI Contents

More information